CML Highlights of the 63rd ASH Annual Meeting

CML Highlights of the 63rd ASH Annual Meeting
Join our two experts to hear about key aspects of the scientific program such as the Live Q&A Session on CML: 'Success breeds more success', the ASH-FDA Joint Symposium on newly approved drugs: 'Treatment landscape in the era of novel therapies' and oral and poster abstracts on basic and translational research in CML, mechanisms of resistance and expanded therapies and progress with response predictors and TKI discontinuation.

Professor Susan Branford, SA Pathology / Centre for Cancer Biology, Adelaide (Australia)
Associate Professor Charles Chuah Thuan Heng, Duke NUS Medical School (Singapore)

Date: December 23rd at 13.00 Central European Time (CET)

How can I dial into the webinar?
Please join this meeting from your computer, tablet or smartphone via the link:

https://us02web.zoom.us/j/84231232033
Meeting-ID: 842 3123 2033

At what time does the webinar take place in my time zone?

ACST – Australian Central Standard Time: 22.30
BRT – Brazilian Time: 09.00
CAT – Central African Time: 13.00
CST – China Standard Time: 20.00
EAT – East Africa Time: 14.00
EST – Eastern Standard Time: 07.00
GMT – Greenwich Mean Time: 12.00
IST – Indian Standard Time: 17.30
SGT – Singapore Time: 20:00

If you have any questions or need assistance, please email to
stefanie@cml-foundation.org

We are pleased to share that we will continue the monthly iCMLf Conversations in 2022. Your suggestions for topics or experts are most welcome.
Please email your ideas to info@cml-foundation.org